Lateral Flow Assay Market – F. Hoffmann-La Roche AG released Elecsys CSF immunoassays

Anatomic Pathology Market

Abbott Laboratories is one of the leading American health care company situated in Illinois, United States. Abbott has an extensive range of branded medical devices, generic pharmaceuticals, diagnostics, and nutrition products.

In 2017, Abbott Laboratories collaboration with Alere company to develop a reliable, diagnostics, diverse portfolio of devices, nutritionals, and branded generic pharmaceuticals.

In 2018, F. Hoffmann-La Roche AG released Elecsys CSF immunoassays (LFIA)

To know more, read @

Market Overview

Market Data Forecast published a report named Lateral Flow Assay Market. The Global Lateral Flow Assay Market Size has estimated to reach at 8.2% CAGR from 2018 to 2023, and it has determined that the global market worth was USD 6.51 billion in 2018 and it was expected to reach USD 9.65 billion by 2023.

Report segmented as:

By Product:

  • Reader
  • Kit


  • Clinical (Pregnancy, Infectious Disease, Lipid, Cardiac Marker)
  • Veterinary
  • Drug Development
  • Food Safety

Aspects such as technological progressions and rising product acceptance are likely to drive the global lateral flow assay market. However, strict regulation and inconsistency in test results have expected to detain the global lateral flow assay market.

Geographical Segmentation:

Based on geography, the market divided under many countries namely, North America, Asia-Pacific, Europe, Latin America and the Middle East and Africa. North America and Europe have to lead the Lateral Flow Assay Market, and Asia-Pacific estimated to reach the highest rate.

Key market players:

  • Hoffmann-La Roche AG (Switzerland)
  • Abbott Laboratories (US)
  • Siemens AG (Germany)
  • Danaher Corporation (US)
  • Dickinson and Company (US)
  • Becton
  • Bio-Rad Laboratories, Inc. (US)
  • bioMérieux SA (France)
  • QIAGEN N.V. (The Netherlands)
  • Thermo Fisher Scientific Inc. (US)
  • Hologic, Inc. (US)
  • PerkinElmer, Inc. (US)
  • Quidel Corporation (US)
  • Merck Millipore (US)
  • DCN Diagnostics (US)
  • Abcam plc. (US)
  • Surmodics, Inc. (US)

View a sample and decide @

The Scope of the report:

The report offers a comprehensive examination of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along with this, the factors influential in influencing the market dynamics and trends discussed in detail at the product level. Further, the performance of the market at the regional and country-level had assessed, and the prospects with huge growth potential identified and debated.

The key players in the industry are profiled giving insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategical activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry had provided. The report also provides a broad outlook of the current market along with recommendations from industry experts on the opportunities for investment activity.

What else? Apart from the syndicated report, our in-house team has expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions.

About Us:

Market Data Forecast is a firm working in the areas of market research, business intelligence and research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.

For more information:   

Abhishek Shukla

Sales Manager at Market Data Forecast


Tel: +1-888-702-9626


Be the first to comment

Leave a Reply

Your email address will not be published.